Mepolizumab significantly reduced the annualized rate of moderate or severe exacerbations in COPD with an eosinophilic ...

An investigational blood test for type 1 diabetes can accurately detect the disorder's characteristic autoimmunity with only ...

The following is a summary of “Evaluation of clinical impact of Interleukin 8 gene expression in patients with fibromyalgia,” published in the April 2025 issue of Advances in Rheumatology by Amorim et ...

Topical deep delivery of corticosteroids into the sinonasal cavity improves symptoms and sleep in patients with chronic rhinosinusitis.

Researchers explore the medicinal role of curcumin in the treatment and prevention of neuroinflammation and metabolic ...

Recent years have seen significant advancements in UC treatment, offering renewed hope for patients seeking effective and ...

Updated findings from a phase 2 study investigating the IL-2–binding monoclonal antibody AU-007 show a manageable safety ...

An investigator reported updated findings from the phase 2/3 study QUILT 3.032 using a July 15, 2024 data cutoff.

Researchers from the Ernst Strüngmann Institute for Neuroscience, the MIND Foundation, alongside other collaborators, have ...

Biologics targeting interleukin (IL)-12, IL-23, and IL-17 may have valuable safety benefits among older adults with psoriatic disease, as a lower rate of serious infection was observed among these ...

The following is a summary of “Exploration of the association between 91 inflammatory proteins and immune thrombocytopenia: a ...